16 November 2026 in JBMR Plus
Cold exposure has recently emerged as a physiological modifier of skeletal regeneration, although the mechanisms linking temperature to osteogenesis remain incompletely understood. The calcium-sensing receptor (CaSR), a regulator of extracellular calcium homeostasis and bone-cell function, represents a potential link between temperature-responsive signaling and fracture repair. This study investigated whether acute cold exposure alters CaSR expression during bone healing and whether the resulting biological context influences responses to parathyroid hormone (PTH 1–34) or pharmacological CaSR targeting with R568. Using a murine bilateral femoral fracture model, male C57BL/6 mice were used to reduce variability associated with cyclical ovarian hormone fluctuations, which can influence bone turnover, calcium homeostasis, and PTH responsiveness. Animals received cold exposure, PTH, R568, or their respective combinations. Cold treatment significantly increased CaSR expression by 5.57% compared with untreated fractures and increased callus BV/TV by approximately 13.5%, together with changes in mineralization-related outcomes. PTH treatment was associated with elevated total serum calcium and did not significantly increase callus BV/TV, BMD, or trabecular thickness at day 14. Addition of cold significantly reduced serum calcium relative to PTH alone and was associated with higher callus BV/TV and TMD and lower trabecular and cortical separation. R568 was used to pharmacologically target CaSR in the context of cold-induced increased CaSR expression. Compared with R568 alone, R568 + Cold treatment resulted in higher callus BV/TV (40.82% vs. 30.92%) and TMD, together with increased ALP and CD34 staining. Collectively, these findings identify increased CaSR expression as a prominent feature of the cold-responsive fracture-healing environment and suggest that this state may influence responses to both anabolic and CaSR-targeted interventions. These results provide a foundation for investigating the interface between thermal biology, calcium regulation, and pharmacological targeting of CaSR as a potential strategy for enhancing fracture repair.